The Center of Molecular Immunology (CIM) in Havana has suspended eight of its ten active clinical trials. This shutdown stems directly from infrastructure failure, specifically citing the 'de facto oil blockade imposed by the United States,' which causes power outages and collapses transport systems.

Commenters pointed fingers at external constraints and internal mismanagement. Several arguments focused on the US sanctions being the root cause of the struggle. On the other side, contributors noted the ingenuity of figures like Kalet León Monzón, who developed monoclonal antibodies using 'nontraditional ways' for reagents, suggesting scientific persistence despite the backdrop.

The weight of the reporting points to a crisis driven by external geopolitical pressure. The operational failure of critical research at CIM is presented as a direct consequence of the US blockade's tangible effects on Cuba's infrastructure.